Arrowstreet Capital, Limited Partnership Collegium Pharmaceutical, Inc Put Options Transaction History
Arrowstreet Capital, Limited Partnership
- $114 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding COLL
# of Institutions
252Shares Held
38.9MCall Options Held
84.2KPut Options Held
19.6K-
Black Rock Inc. New York, NY5.79MShares$175 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.63MShares$79.5 Million1.49% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$78.2 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$70.8 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.75MShares$52.7 Million0.04% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.03B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...